| abstract |
A non-injectable IV formulation of amisulpride, for use in the treatment or prevention of delayed-phase chemotherapy or radiotherapy-induced nausea and / or vomiting (CINV / RINV) in a subject, wherein the subject is receiving or has received a regimen of chemotherapy or radiotherapy treatment on day 1, and where the dosage regimen comprises the administration of a 5-15 mg dose of the non-injectable amisulpride IV on each of days 2, 3 and 4, and further where the subject is receiving or has received an acute phase antiemetic on day 1, wherein the acute phase antiemetic is an antiemetic that is suitable for use in the acute phase of CINV or RINV. |